(Total Views: 506)
Posted On: 05/06/2025 2:28:05 PM
Post# of 154595
December 2024
Quote:
Third, we have finalized the protocol for a pilot study of leronlimab in the treatment of patients with mild to moderate Alzheimer’s disease.
Ihttps://www.cytodyn.com/newsroom/press-releases/detail/633/december-2024-letter-to-shareholders

